Citations 1
PB2032: MAGNETISMM-9: AN OPEN-LABEL, MULTICENTER, NON-RANDOMIZED PHASE 1/2 STUDY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
Fonseca, R., Kuroda, J., Ishida, T., Popat, R., HUANG, Jeffrey Shang-Yi, Yver, A., Vandendries, E., Elmeliegy, M., Ma, W. D., Sborov, D. W., Fonseca, R., Ishida, Tadao , Popat, R., Ma, W. D., Sborov, Douglas W.
HemaSphere | June 24, 2022 | Volume: 6 | Issue: No issue available | Pages: 1903-1904
